Yahoo Finance1h
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
Regulatory approval to initiate first-in-human study with a miniature, ultra long-acting GLP-1 (exenatide) implant in obese ...
Amgen dismisses bone density concerns related to its weight-loss drug
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...
Hosted on MSN18h
What You Need To Know about Compounded Medications
Semaglutide (sold under brand names like Ozempic and Wegovy) and tirzepatide (sold under brand names like Mounjaro and ...